However, VHL-silenced HER2-CAR-T cells were able to decrease tumour growth significantly, and an improved animal survival relative to NTC-expressing CAR-T cells was seen, clearing tumours in 2 of the 11 animals analysed (Figure 3K and L). The gene discussed is VHL; the disease is neoplasm.